Recent Quarter Total Invested
$5.72 M
Recent Quarter Institutional Ownership Percentage
14.85%
Total Invested of Last Quarter
$3.23 M
Ownership Percentage of Last Quarter
8.26%
Lexaria Bioscience Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 1.02 M | $2.84 M | 100.00% | 7.36% |
| INVENOMIC CAPITAL MANAGEMENT LP | 08/14/2024 | 513,573 | $1.43 M | 8.52% | 3.71% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 114,783 | $319,193 | 15.55% | 0.83% |
| VANGUARD GROUP INC | 08/13/2024 | 93,586 | $260,169 | 9.90% | 0.68% |
| GENTRUST, LLC | 08/09/2024 | 60,000 | $166,800 | 100.00% | 0.43% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 07/19/2024 | 48,800 | $135,664 | 23.39% | 0.35% |
| STATE STREET CORP | 08/14/2024 | 39,301 | $109,257 | 0.00% | 0.28% |
| BLACKROCK INC. | 08/13/2024 | 27,445 | $76,297 | 1,719.96% | 0.20% |
| WELCH GROUP, LLC | 07/17/2024 | 24,000 | $66,720 | 0.00% | 0.17% |
| MORGAN STANLEY | 08/14/2024 | 22,982 | $63,890 | -1.59% | 0.17% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 22,800 | $63,384 | 100.00% | 0.16% |
| NORTHERN TRUST CORP | 08/14/2024 | 18,389 | $51,121 | 0.00% | 0.13% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 07/16/2024 | 13,823 | $38,428 | 33.90% | 0.10% |
| XTX TOPCO LTD | 08/12/2024 | 12,602 | $35,034 | 22.64% | 0.09% |
| ROYAL BANK OF CANADA | 08/14/2024 | 7,283 | $20,000 | 0.00% | 0.05% |
| OAKWORTH CAPITAL, INC. | 07/19/2024 | 5,000 | $13,900 | 0.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 3,370 | $9,369 | 24.72% | 0.02% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 3,300 | $9,174 | 207.55% | 0.02% |
| 1832 ASSET MANAGEMENT L.P. | 08/13/2024 | 2,686 | $7,467 | 0.00% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 2,290 | $6,366 | 4.57% | 0.02% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 945 | $2,627 | -96.45% | 0.01% |
| ASPIRE PRIVATE CAPITAL, LLC | 07/15/2024 | 400 | $1,112 | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 07/31/2024 | 166 | $458 | 0.00% | 0.00% |
| MATHER GROUP, LLC. | 07/09/2024 | 100 | $363 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 96 | $267 | -59.49% | 0.00% |
| ALLWORTH FINANCIAL LP | 07/24/2024 | 89 | $243 | 0.00% | 0.00% |
| TORONTO DOMINION BANK | 08/14/2024 | 13 | $36 | 0.00% | 0.00% |
| GABLES CAPITAL MANAGEMENT INC. | 08/08/2024 | 13 | $36 | 0.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Lexaria Bioscience Corp.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of LEXX shares?
During the previous two years, 30 institutional investors and hedge funds held shares of Lexaria Bioscience Corp.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 1.02 M
Invenomic Capital Management LP: 513,573
GEODE CAPITAL MANAGEMENT, LLC: 114,783
VANGUARD GROUP INC: 93,586
GenTrust, LLC: 60,000
Raymond James Financial Services Advisors, Inc.: 48,800
-
What percentage of Lexaria Bioscience Corp. stock is owned by institutional investors?
14.85% of Lexaria Bioscience Corp. stock is owned by institutional investors.
-
How much institutional buying is happening at LEXX ?
Institutional investors have bought a total of 2.06 M shares in the last 24 months. This purchase volume represents approximately $6.59 M in transactions.